SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $109,137,904 | -34.7% | 953,003 | -21.5% | 0.13% | -38.3% |
| Q1 2023 | $167,236,857 | +138579.9% | 1,213,356 | +30.4% | 0.21% | +20.1% |
| Q4 2022 | $120,592 | -99.8% | 930,643 | +39.5% | 0.17% | +59.6% |
| Q3 2022 | $73,735,000 | +725.3% | 667,044 | +459.7% | 0.11% | +808.3% |
| Q2 2022 | $8,934,000 | +30.2% | 119,187 | +35.7% | 0.01% | +50.0% |
| Q1 2022 | $6,863,000 | -17.3% | 87,856 | -4.7% | 0.01% | 0.0% |
| Q4 2021 | $8,297,000 | +10.9% | 92,142 | +13.9% | 0.01% | 0.0% |
| Q3 2021 | $7,479,000 | – | 80,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |